Growth Metrics

Opus Genetics (IRD) Shareholder's Equity (QoQ) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Opus Genetics 357.99 Mn 298.03 Mn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -398.64%
Dec 31, 2025 157.21%
Sep 30, 2025 -65.85%
Jun 30, 2025 244.43%
Mar 31, 2025 -24.55%
Dec 31, 2024 -80.40%
Sep 30, 2024 -15.59%
Jun 30, 2024 -11.77%
Mar 31, 2024 -7.71%
Dec 31, 2023 -0.75%
Sep 30, 2023 33.36%
Jun 30, 2023 -8.60%
Mar 31, 2023 -10.79%
Dec 31, 2022 289.32%
Sep 30, 2022 -18.62%
Jun 30, 2022 -15.50%
Mar 31, 2022 -22.28%
Dec 31, 2021 8.05%
Sep 30, 2021 -8.81%
Jun 30, 2021 129.76%
Mar 31, 2021 172.89%
Dec 31, 2020 -43.11%
Sep 30, 2020 -7.20%
Jun 30, 2020 -3.75%
Mar 31, 2020 -11.92%
Dec 31, 2019 -164.31%
Sep 30, 2019 -13.71%
Jun 30, 2019 -14.53%
Mar 31, 2019 1,038.20%
Dec 31, 2018 -126.50%
Sep 30, 2018 -43.87%
Jun 30, 2018 -23.69%
Mar 31, 2018 -10.73%
Dec 31, 2017 10.90%
Sep 30, 2017 -4.91%
Jun 30, 2017 1,307.76%
Mar 31, 2017 -93.38%
Dec 31, 2016 -1.05%
Sep 30, 2016 9.01%
Jun 30, 2016 -8.10%
Mar 31, 2016 -8.34%
Dec 31, 2015 6.04%
Sep 30, 2015 -17.37%
Jun 30, 2015 -8.34%
Mar 31, 2015 -12.05%
Dec 31, 2014 -7.05%
Sep 30, 2014 -5.65%
Jun 30, 2014 8.12%
Mar 31, 2014 122.03%
Dec 31, 2013 28.16%
Sep 30, 2013 79.04%
Jun 30, 2013 -34.31%
Mar 31, 2013 -12.15%
Dec 31, 2012 101.25%
Sep 30, 2012 -38.20%
Jun 30, 2012 -11.45%
Mar 31, 2012 -19.14%
Dec 31, 2011 5.25%
Sep 30, 2011 -11.38%